Henry Schein (NASDAQ:HSIC) Issues Quarterly Earnings Results

Henry Schein (NASDAQ:HSIC) posted its earnings results on Tuesday. The company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.16 by $0.06, Briefing.com reports. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter last year, the firm earned $1.32 earnings per share. The company’s revenue was up .4% on a year-over-year basis. Henry Schein updated its FY 2024 guidance to 4.740-4.820 EPS.

Henry Schein Trading Up 1.1 %

HSIC traded up $0.78 during trading on Wednesday, reaching $69.77. 980,859 shares of the stock traded hands, compared to its average volume of 1,346,360. The stock’s 50-day moving average is $70.60 and its 200 day moving average is $69.78. Henry Schein has a 12 month low of $62.05 and a 12 month high of $82.63. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $8.84 billion, a PE ratio of 25.86, a P/E/G ratio of 2.02 and a beta of 0.87.

Analyst Ratings Changes

A number of analysts have issued reports on HSIC shares. Barrington Research reissued an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a report on Wednesday. StockNews.com cut Henry Schein from a “hold” rating to a “sell” rating in a research note on Wednesday, October 30th. Evercore ISI increased their price target on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. Finally, Robert W. Baird reduced their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a report on Wednesday, August 7th. Two analysts have rated the stock with a sell rating, five have given a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Henry Schein has a consensus rating of “Hold” and an average target price of $77.50.

Insider Activity

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.14% of the stock is owned by company insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.